NCT04111107 2024-07-03
Precision Medicine for Patients With Identified Actionable Mutations
Wake Forest University Health Sciences
Phase 2 Terminated
Clinical Trials
3 trialsNCT05768503 2023-03-14
Comparing Chidamide+Sintilimab+Bev With Standard Second-line FOLFIRI+Bev in Advanced MSS/pMMR mCRC
Sun Yat-sen University
Phase 3 Recruiting
NCT05409417 2022-06-08
Exploratory Study on Combined Conversion Immunotherapy for Liver Metastasis of MSS Type Initial Unresectable Colorectal Cancer Based on Gene Status
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2/3 Unknown